Lonza Group AG (LZAGY)
OTCMKTS · Delayed Price · Currency is USD
67.47
-0.50 (-0.74%)
Oct 9, 2025, 3:47 PM EDT
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of $47.41 billion as of October 9, 2025. Its market cap has increased by 4.13% in one year.
Market Cap
47.41B
Enterprise Value
52.08B
Revenue
8.92B
Ranking
n/a
PE Ratio
51.44
Stock Price
$67.47
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 3.78B to 47.41B, an increase of 1,154.54%. That is a compound annual growth rate of 10.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 47.41B | 11.13% |
| Dec 30, 2024 | 42.67B | 36.74% |
| Dec 29, 2023 | 31.20B | -14.17% |
| Dec 30, 2022 | 36.35B | -41.26% |
| Dec 30, 2021 | 61.89B | 29.41% |
| Dec 30, 2020 | 47.82B | 76.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 331.81M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |